lung-cancer

Documents about lung-cancer

• Radiology artificial intelligence for prioritized imaging and diagnosis of lung cancer: qualitative interview analysis of stakeholder perspectives in Northern Ireland.#25659NCBI PubMed Central
• Artificial intelligence and machine learning in non-small cell lung cancer: the current state of the science on multi-omic applications.#25830NCBI PubMed Central
• Normal tissue complication probability modeling of severe radiation-induced lymphopenia using blood dose for lung cancer patients treated with IMRT and IMPT.#125429NCBI PubMed Central
• ThermoTargetMiner as a proteome integral solubility alteration target database for prospective drugs against lung cancer#135547Unpaywall
• Deep feature optimization using fusion of multiple self-supervised learning approaches and filter-based feature selection for lung cancer histopathology classification.#140564NCBI PubMed Central
• Circulating and Molecular Markers Involved in the Processes of Cachexia, Anorexia and Sarcopenia in Patients With NSCLC#148774ClinicalTrials.gov
• Costs of biomarker testing in advanced non‐small cell lung cancer: a global study comparing next‐generation sequencing and single‐gene testing#155996HAL (France)
• Patient Reported Outcome Measurements (PROMs) Impact on Clinical Outcome in firsT Line settIng Non- Small-Cell Lung Cancer (NSCLC) According to Chemo- Immunotherapy reGimen#160373ClinicalTrials.gov
• Impact of video-assisted thoracoscopic lobectomy versus open lobectomy for lung cancer on recovery assessed using self-reported physical function: VIOLET RCT#183841Ora Oxford University Research
• Tailored personas for anticipatory grief management among primary family caregivers of patients with advanced lung cancer in China: a qualitative study.#185765NCBI PubMed Central
• Real-world efficacy of atezolizumab combined with etoposide and platinum chemotherapy in extensive-stage small cell lung cancer: a retrospective cohort study#208779HAL (France)
• Development and validation of an MRI-based clinical-radiomics nomogram for predicting lymph node metastasis in non-small cell lung cancer.#220974NCBI PubMed Central
• WHENII - Early Response Evaluation With FDG-PET/CT and Liquid Biopsy in Patients With NSCLC#234423ClinicalTrials.gov
• Immunodynamics-Guided Optimization of Individualized Immunochemotherapy in Advanced Driver-Negative NSCLC: A Randomized Trial#311116ClinicalTrials.gov
• Phase 1b Study of Dato-DXd in Combination With Immunotherapy With or Without Carboplatin in Advanced or Metastatic Non-Small Cell Lung Cancer#311140ClinicalTrials.gov
• Electroacupuncture Combined With PD-1 Inhibitor for Elderly Patients With Advanced NSCLC#366609ClinicalTrials.gov
• Decrease in Risk of Lung Cancer Death in Males after Smoking Cessation by Age at Quitting : Findings from the JACC Study#384121CiNii
• Frailty, initial attrition and the potential use of novel platinum-free options for non-small-cell lung cancer in the real-world setting#410898bioRxiv / medRxiv
• Metabolomic Characteristics of Patients With Non-Small Cell Lung Cancer in Plasma, Tissue and Exhaled Breath Condensate: A Case-Control Study.#422944NCBI PubMed Central
• Long-term comparative effectiveness of tepotinib versus standard of care for MET exon 14 skipping-mutated non-small cell lung cancer.#433869NCBI PubMed Central
• CMA-associated cellular state remodeling defines prognostic heterogeneity and identifies ARRDC3 as a protective functional gene in small cell lung cancer.#436949NCBI PubMed Central
• Cytotoxic Activity of N-Hexane, Ethyl Acetate, and Ethanol Extract of Hibiscus tiliaceus against A549 Lung Cancer Cells#444154utndrepository
• Modified Short-Course Radiotherapy Combined With Immunochemotherapy and Targeted Therapy as First-Line Treatment for MSS Metastatic Colorectal Cancer#321692ClinicalTrials.gov
• Lung cancer risk in relation to indicative radon atlas metrics in Northern Ireland: a population-based case-control study using secondary data.#4138NCBI PubMed Central
• Lorlatinib Versus Crizotinib in Patients With Advanced ALK -Positive Non–Small Cell Lung Cancer: 5-Year Outcomes From the Phase III CROWN Study#11480HAL (France)
• Predicthor: AI-Powered Predictive Risk Model for 30-Day Mortality and 30-Day Complications in Patients Undergoing Thoracic Surgery for Lung Cancer#20664HAL (France)
• Construction of CT Radiomics Model for Predicting the Efficacy of Immunotherapy in Patients With Stage III NSCLC#141001ClinicalTrials.gov
• Veliparib in Combination With Platinum-Based Chemotherapy for First-Line Treatment of Advanced Squamous Cell Lung Cancer: A Randomized, Multicenter Phase III Study#161207HAL (France)
• Prediction models for early detection and diagnosis of lung cancer in people who have never smoked: a systematic review and critical appraisal.#213988NCBI PubMed Central
• Explainable 1-mm Peritumoral CT Radiomics for EGFR Mutation Prediction in Non-small Cell Lung Cancer: A Vietnamese Real-World Cohort Study.#236072NCBI PubMed Central
• Implementation of patient-reported outcomes in personalized lung cancer care: a qualitative study from the perspective of patients and health care providers.#242092NCBI PubMed Central
• FLT3L-secreting cDC1 in situ vaccination enhances antitumor immunity and synergizes with PD-1 blockade in murine non-small cell lung cancer.#322954NCBI PubMed Central
• Molecular residual disease-based novel modality of postoperative management for non-small-cell lung cancer (REMODEL): Protocol for a prospective multicenter study.#334743NCBI PubMed Central
• Research on Predicting the Efficacy of Immunotherapy for Non-small Cell Lung Cancer Based on CT Radiomics and Peripheral Blood Inflammatory Markers.#342464NCBI PubMed Central
• METTL3- and IGF2BP1-associated m6A regulation of FADS2 contributes to lipid droplet accumulation and malignant progression in non-small cell lung cancer.#368075NCBI PubMed Central
• Study of ARRY-614 Plus Either Nivolumab or Nivolumab+Ipilimumab#369832ClinicalTrials.gov
• Randomized Trial of Glutathione With Anti-PD-1 and Chemotherapy in Advanced NSCLC#390912ClinicalTrials.gov
• Agreement and workflow efficiency of AI-based coronary artery calcification quantification in lung cancer screening: Comparison with semi-automated and visual assessment.#406568PubMed
• Expression and clinical significance of LncRNA <i>CRNDE, XIAP</i>, and <i>XAF1</i> in non-small cell lung cancer#357071Figshare
• Cost-effectiveness analysis of tepotinib vs capmatinib as subsequent therapy in MET exon 14-mutated non-small-cell lung cancer#4488Europe PMC
• Identifying the Initiation of a New Line of Therapy for Metastatic Lung, Breast, and Colorectal Cancer in Real-World Data: A Scoping Review.#143156NCBI PubMed Central
• Carboplatin Plus Pemetrexed Plus Atezolizumab Plus Bevacizumab in Chemotherapy and Immunotherapy-naïve Patients With Stage IV Non-squamous Non-small Cell Lung Cancer#146448ClinicalTrials.gov
• A reduction-sensitive lipophilic dihydroartemisinin prodrug in a self-microemulsifying drug delivery system for treating breast cancer lung metastasis via intestinal lymphatic transport.#170757NCBI PubMed Central
• Envafolimab Immunotherapy After ctDNA EGFR Clearance by Treatment With Almonertinib in EGFR-Mutant, PD-LI Positive NSCLC#174860ClinicalTrials.gov
• Evaluation of kidney stone–related renal infection status by 18F-FDG PET/CT in lung cancer patients with concomitant nephrolithiasis: a multicenter study.#255483NCBI PubMed Central
• Effect of Low-dose Radiotherapy on Tumor Immune Microenvironment in Oligometastases of NSCLC After Immunotherapy#268002ClinicalTrials.gov
• Development of an Artificial Intelligence Web Application for Predicting Chemotherapy-Induced Neutropenia in Patients With Non-Small Cell Lung Cancer: A Prospective Study.#275463NCBI PubMed Central
• Structured Expert Elicitation of Long-Term Survival in Non-small Cell Lung Cancer: A Case Study Applying Guidance from NICE Technical Support Document 26.#275736NCBI PubMed Central
• EGFR Exon 20 Insertion–Mutated Non-Small Cell Lung Cancer: Current Treatment Landscape and Future Directions#306093Springer Nature OA
• Development and initial validation of a scale assessing sources of decision hesitation in patients with lung cancer invited to participate in drug clinical trials.#323137NCBI PubMed Central